葡萄糖皮质类药物通过抑制GARP/TGF-β轴来释放免疫依赖的黑色素瘤控制
bioRxiv : the preprint server for biology
|August 6, 2025
概括
葡萄糖皮质醇通过直接降低瘤细胞GARP,抑制TGF-β信号传递并使T细胞死亡,控制黑色素瘤. 这一发现为改善癌症免疫治疗反应提供了新的治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
背景情况:
- 晚期黑色素瘤患者经常抵抗免疫检查点阻塞,需要新的治疗策略.
- 葡萄糖皮质类药物是广泛用于皮肤疾病的局部治疗方法,具有尚未探索的抗癌潜力.
研究的目的:
- 在免疫治疗耐药黑色素瘤模型中研究局部药物的抗癌活性.
- 阐明葡萄糖皮质体调解抗瘤作用的机制.
主要方法:
- 使用了一种对免疫疗法耐药的小鼠黑色素瘤模型.
- 在各种细胞区中使用葡萄糖皮质体受体的基因切除.
- 分析了黑色素瘤患者样本的葡萄糖皮质体受体和GARP表达,以及瘤透淋巴细胞中的TGF-β信号传递.
主要成果:
- 葡萄糖皮质类药物诱导了快速细胞毒性T淋巴细胞 (CTL) 依赖的瘤控制.
- 葡萄糖皮质类药物直接作用于瘤细胞,降低GARP的调节,从而抑制TGF-β信号传递并增强CTL活性.
- 在患者中,高葡萄糖皮质体受体表达与预后改善和CTLs中TGF-β信号减少相关.
- 高GARP表达与生存率降低有关,特别是在接受免疫治疗的患者中.
结论:
- GARP/TGF-β轴是癌细胞内在的免疫逃避机制,对葡萄糖皮质体敏感.
- 葡萄糖皮质类药物可以通过向GARP/TGF-β通路来克服免疫抵抗.
- GARP可以作为免疫治疗反应的预测生物标志物和治疗标.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
203
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
203
TGF - β Signaling Pathway
7.6K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
GPCRs Regulate Adenylyl Cylase Activity
5.9K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.9K
T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
Mitogens and the Cell Cycle
6.8K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.8K


